WCLC 2023 | HANSE: effectiveness of NELSON vs. PLCOm2012 lung cancer screening

Jens Vogel-Claussen, MD, Hannover Medical School, Hannover, Germany, discusses final results from the German HANSE study (NCT04913155), which aimed to assess the effectiveness of two different eligibility criteria models for lung cancer screening: the Netherlands Leuvens Longkanker Screenings Onderzoek (NELSON) and PLCOm2012 models. The PLCOm2012 criteria were found to be reliable and more efficient, suggesting their preference for identifying high-risk individuals in lung cancer screening programs. Longitudinal outcome analysis is planned for further assessment. This interview took place at the 2023 World Conference on Lung Cancer (WCLC) in Singapore, Singapore.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.